Astria Therapeutics Inc (ATXS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -36,060 | -27,282 | -18,863 | -9,418 | -32,630 |
| Depreciation Amortization | 395 | 300 | 195 | 92 | 202 |
| Accounts payable and accrued liabilities | 77 | 178 | 210 | 230 | 196 |
| Other Working Capital | 274 | 257 | -578 | -486 | 684 |
| Other Operating Activity | 2,456 | 1,673 | 1,060 | 435 | 1,755 |
| Operating Cash Flow | $-32,858 | $-24,874 | $-17,976 | $-9,147 | $-29,793 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -407 | -387 | -363 | -290 | -421 |
| Purchase Of Investment | -45,539 | -41,497 | -32,111 | -32,111 | N/A |
| Sale Of Investment | 30,456 | 20,584 | 13,503 | 3,332 | N/A |
| Investing Cash Flow | $-15,490 | $-21,300 | $-18,971 | $-29,069 | $-421 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | -833 | 5,000 |
| Debt Repayment | -3,333 | -2,500 | -1,666 | N/A | -833 |
| Common Stock Issued | 12,497 | 12,358 | 111 | 87 | 61,835 |
| Other Financing Activity | 0 | 0 | 0 | 0 | 12,324 |
| Financing Cash Flow | $9,164 | $9,858 | $-1,555 | $-746 | $78,326 |
| Beginning Cash Position | 62,780 | 62,780 | 62,780 | 62,780 | 14,668 |
| End Cash Position | 23,596 | 26,464 | 24,278 | 23,818 | 62,780 |
| Net Cash Flow | $-39,184 | $-36,316 | $-38,502 | $-38,962 | $48,112 |
| Free Cash Flow | |||||
| Operating Cash Flow | -32,858 | -24,874 | -17,976 | -9,147 | -29,793 |
| Capital Expenditure | -459 | -436 | -388 | -290 | -421 |
| Free Cash Flow | -33,317 | -25,310 | -18,364 | -9,437 | -30,214 |